150 related articles for article (PubMed ID: 16082635)
1. Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus.
Sarabi ZS; Chang E; Bobba R; Ibanez D; Gladman D; Urowitz M; Fortin PR
Arthritis Rheum; 2005 Aug; 53(4):609-12. PubMed ID: 16082635
[No Abstract] [Full Text] [Related]
2. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
3. Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus.
Hinojosa-Azaola A; Romero-Diaz J; Vargas-Ruiz AG; Nuñez-Alvarez CA; Cicero-Casarrubias A; Ocampo-Torres MC; Sanchez-Guerrero J
J Rheumatol; 2016 Mar; 43(3):576-86. PubMed ID: 26773122
[TBL] [Abstract][Full Text] [Related]
4. Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus.
Chang ER; Pineau CA; Bernatsky S; Neville C; Clarke AE; Fortin PR
J Rheumatol; 2006 Sep; 33(9):1780-4. PubMed ID: 16832849
[TBL] [Abstract][Full Text] [Related]
5. Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - a prospective family cohort study in asymptomatic subjects.
Mäkelburg AB; Lijfering WM; Middeldorp S; Hamulyák K; Veeger NJ; Prins MH; Büller HR; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):209-12. PubMed ID: 19132211
[No Abstract] [Full Text] [Related]
6. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
8. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
9. [Thrombolytic therapy with urokinase in two systemic lupus erythematosus patients with deep vein thrombosis].
Hu YQ; Yang PZ; Zuo XX
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):575-6. PubMed ID: 12658949
[No Abstract] [Full Text] [Related]
10. Development of paroxysmal nocturnal haemoglobinuria in systemic lupus erythematosus: an unusual cause of portal vein thrombosis.
Gupta A; Al Fulaij R; Gupta RK; Gupta G; Marouf R
Lupus; 2009 Jul; 18(8):743-6. PubMed ID: 19502272
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid syndrome in systemic lupus erythematosus.
Hill GS; Nochy D
J Am Soc Nephrol; 2007 Sep; 18(9):2461-4. PubMed ID: 17699810
[TBL] [Abstract][Full Text] [Related]
12. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset.
Romero-Díaz J; García-Sosa I; Sánchez-Guerrero J
J Rheumatol; 2009 Jan; 36(1):68-75. PubMed ID: 19012362
[TBL] [Abstract][Full Text] [Related]
15. Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective.
Lijfering WM; Flinterman LE; Vandenbroucke JP; Rosendaal FR; Cannegieter SC
Semin Thromb Hemost; 2011 Nov; 37(8):885-96. PubMed ID: 22198853
[TBL] [Abstract][Full Text] [Related]
16. ABO blood group does not increase the risk of thrombosis in Philadelphia-negative myeloproliferative disorders.
Moreno MJ; Lozano ML; Ferrer F; Bellosillo B; Besses C; Vicente V; Martínez C
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):390-2. PubMed ID: 19542939
[No Abstract] [Full Text] [Related]
17. [Thrombohemorrhagic syndrome in systemic lupus erythematosus].
Iakimova NIa; Sukhanov AA
Klin Med (Mosk); 1974 Jan; 52(1):37-41. PubMed ID: 4466883
[No Abstract] [Full Text] [Related]
18. [Thrombosis and antiprothrombinase in children. Apropos of 2 cases].
Pincemaille O; Plantaz D; Pouzol P; Laudat F; Bost M
Pediatrie; 1988; 43(2):149-54. PubMed ID: 3293012
[TBL] [Abstract][Full Text] [Related]
19. Successful renal transplantation in the right iliac fossa 2 years after serious deep venous thrombosis in a patient with systemic lupus erythematosus.
Tsuchiya N; Satoh S; Narita S; Shimoda N; Matsuura S; Ohyama C; Sato K; Kato T; Ohtani H; Komatsuda A; Habuchi T
Int J Urol; 2005 Oct; 12(10):912-6. PubMed ID: 16323987
[TBL] [Abstract][Full Text] [Related]
20. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus.
Booth S; Chohan S; Curran JC; Karrison T; Schmitz A; Utset TO
Arthritis Rheum; 2007 Jun; 57(5):845-50. PubMed ID: 17530685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
